CN104351778A - Nutritive composition with function of reducing blood fat, and application of nutritive composition - Google Patents
Nutritive composition with function of reducing blood fat, and application of nutritive composition Download PDFInfo
- Publication number
- CN104351778A CN104351778A CN201410624532.2A CN201410624532A CN104351778A CN 104351778 A CN104351778 A CN 104351778A CN 201410624532 A CN201410624532 A CN 201410624532A CN 104351778 A CN104351778 A CN 104351778A
- Authority
- CN
- China
- Prior art keywords
- parts
- alimentation composition
- reducing blood
- blood lipid
- condition
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 239000000203 mixture Substances 0.000 title claims abstract description 79
- 210000004369 blood Anatomy 0.000 title claims abstract description 75
- 239000008280 blood Substances 0.000 title claims abstract description 75
- 230000000050 nutritive effect Effects 0.000 title abstract 5
- 239000000843 powder Substances 0.000 claims abstract description 60
- 230000007062 hydrolysis Effects 0.000 claims abstract description 49
- 238000006460 hydrolysis reaction Methods 0.000 claims abstract description 49
- 102000004169 proteins and genes Human genes 0.000 claims abstract description 44
- 108090000623 proteins and genes Proteins 0.000 claims abstract description 44
- 235000013325 dietary fiber Nutrition 0.000 claims abstract description 43
- 235000013312 flour Nutrition 0.000 claims abstract description 35
- 240000008042 Zea mays Species 0.000 claims abstract description 24
- 235000005824 Zea mays ssp. parviglumis Nutrition 0.000 claims abstract description 24
- 235000002017 Zea mays subsp mays Nutrition 0.000 claims abstract description 24
- 235000005822 corn Nutrition 0.000 claims abstract description 24
- 235000012680 lutein Nutrition 0.000 claims abstract description 16
- 239000001656 lutein Substances 0.000 claims abstract description 16
- 229960005375 lutein Drugs 0.000 claims abstract description 16
- KBPHJBAIARWVSC-RGZFRNHPSA-N lutein Chemical compound C([C@H](O)CC=1C)C(C)(C)C=1\C=C\C(\C)=C\C=C\C(\C)=C\C=C\C=C(/C)\C=C\C=C(/C)\C=C\[C@H]1C(C)=C[C@H](O)CC1(C)C KBPHJBAIARWVSC-RGZFRNHPSA-N 0.000 claims abstract description 16
- ORAKUVXRZWMARG-WZLJTJAWSA-N lutein Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C1=C(C)CCCC1(C)C)C=CC=C(/C)C=CC2C(=CC(O)CC2(C)C)C ORAKUVXRZWMARG-WZLJTJAWSA-N 0.000 claims abstract description 16
- KBPHJBAIARWVSC-XQIHNALSSA-N trans-lutein Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C1=C(C)CC(O)CC1(C)C)C=CC=C(/C)C=CC2C(=CC(O)CC2(C)C)C KBPHJBAIARWVSC-XQIHNALSSA-N 0.000 claims abstract description 16
- FJHBOVDFOQMZRV-XQIHNALSSA-N xanthophyll Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C1=C(C)CC(O)CC1(C)C)C=CC=C(/C)C=CC2C=C(C)C(O)CC2(C)C FJHBOVDFOQMZRV-XQIHNALSSA-N 0.000 claims abstract description 16
- 241000209140 Triticum Species 0.000 claims abstract description 15
- 235000021307 Triticum Nutrition 0.000 claims abstract description 15
- 229930182558 Sterol Natural products 0.000 claims abstract description 14
- 150000003432 sterols Chemical class 0.000 claims abstract description 14
- 235000003702 sterols Nutrition 0.000 claims abstract description 14
- WTJKGGKOPKCXLL-RRHRGVEJSA-N phosphatidylcholine Chemical compound CCCCCCCCCCCCCCCC(=O)OC[C@H](COP([O-])(=O)OCC[N+](C)(C)C)OC(=O)CCCCCCCC=CCCCCCCCC WTJKGGKOPKCXLL-RRHRGVEJSA-N 0.000 claims abstract description 11
- 235000007164 Oryza sativa Nutrition 0.000 claims abstract description 10
- 235000009566 rice Nutrition 0.000 claims abstract description 10
- 240000007594 Oryza sativa Species 0.000 claims abstract 2
- 150000002632 lipids Chemical class 0.000 claims description 64
- 102000015636 Oligopeptides Human genes 0.000 claims description 43
- 108010038807 Oligopeptides Proteins 0.000 claims description 43
- 238000002360 preparation method Methods 0.000 claims description 33
- 239000004365 Protease Substances 0.000 claims description 30
- 238000002156 mixing Methods 0.000 claims description 30
- 238000000108 ultra-filtration Methods 0.000 claims description 24
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 20
- 239000002994 raw material Substances 0.000 claims description 19
- 238000004513 sizing Methods 0.000 claims description 18
- 238000005507 spraying Methods 0.000 claims description 18
- 108091005804 Peptidases Proteins 0.000 claims description 15
- 102100037486 Reverse transcriptase/ribonuclease H Human genes 0.000 claims description 15
- 229930014669 anthocyanidin Natural products 0.000 claims description 15
- 150000001452 anthocyanidin derivatives Chemical class 0.000 claims description 15
- 235000008758 anthocyanidins Nutrition 0.000 claims description 15
- 239000000194 fatty acid Substances 0.000 claims description 15
- 238000000034 method Methods 0.000 claims description 15
- 239000000463 material Substances 0.000 claims description 14
- BUGBHKTXTAQXES-UHFFFAOYSA-N Selenium Chemical compound [Se] BUGBHKTXTAQXES-UHFFFAOYSA-N 0.000 claims description 13
- 229910052711 selenium Inorganic materials 0.000 claims description 13
- 239000011669 selenium Substances 0.000 claims description 13
- 244000068988 Glycine max Species 0.000 claims description 12
- 235000010469 Glycine max Nutrition 0.000 claims description 12
- 239000000706 filtrate Substances 0.000 claims description 12
- 239000012528 membrane Substances 0.000 claims description 12
- 239000000047 product Substances 0.000 claims description 12
- 239000002002 slurry Substances 0.000 claims description 12
- 230000001954 sterilising effect Effects 0.000 claims description 12
- 108010082495 Dietary Plant Proteins Proteins 0.000 claims description 8
- 241001465754 Metazoa Species 0.000 claims description 8
- -1 aromatic amino acid Chemical class 0.000 claims description 6
- 238000001914 filtration Methods 0.000 claims description 6
- 238000010438 heat treatment Methods 0.000 claims description 6
- 239000000413 hydrolysate Substances 0.000 claims description 6
- 235000007319 Avena orientalis Nutrition 0.000 claims description 5
- 241000675108 Citrus tangerina Species 0.000 claims description 5
- 240000004922 Vigna radiata Species 0.000 claims description 5
- 235000010721 Vigna radiata var radiata Nutrition 0.000 claims description 5
- 235000011469 Vigna radiata var sublobata Nutrition 0.000 claims description 5
- 241000209763 Avena sativa Species 0.000 claims description 4
- 235000007558 Avena sp Nutrition 0.000 claims description 4
- HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 abstract description 16
- 235000019197 fats Nutrition 0.000 abstract description 11
- 235000012000 cholesterol Nutrition 0.000 abstract description 5
- 108010007622 LDL Lipoproteins Proteins 0.000 abstract description 3
- 102000007330 LDL Lipoproteins Human genes 0.000 abstract description 3
- 238000010521 absorption reaction Methods 0.000 abstract description 3
- 108090000765 processed proteins & peptides Proteins 0.000 abstract description 3
- 235000020660 omega-3 fatty acid Nutrition 0.000 abstract description 2
- 229920001184 polypeptide Polymers 0.000 abstract description 2
- 102000004196 processed proteins & peptides Human genes 0.000 abstract description 2
- HVYWMOMLDIMFJA-UHFFFAOYSA-N 3-cholesterol Natural products C1C=C2CC(O)CCC2(C)C2C1C1CCC(C(C)CCCC(C)C)C1(C)CC2 HVYWMOMLDIMFJA-UHFFFAOYSA-N 0.000 abstract 1
- 235000010208 anthocyanin Nutrition 0.000 abstract 1
- 239000004410 anthocyanin Substances 0.000 abstract 1
- 229930002877 anthocyanin Natural products 0.000 abstract 1
- 150000004636 anthocyanins Chemical class 0.000 abstract 1
- 210000001367 artery Anatomy 0.000 abstract 1
- CYQFCXCEBYINGO-IAGOWNOFSA-N delta1-THC Chemical compound C1=C(C)CC[C@H]2C(C)(C)OC3=CC(CCCCC)=CC(O)=C3[C@@H]21 CYQFCXCEBYINGO-IAGOWNOFSA-N 0.000 abstract 1
- 230000002401 inhibitory effect Effects 0.000 abstract 1
- 229940012843 omega-3 fatty acid Drugs 0.000 abstract 1
- 150000003384 small molecules Chemical class 0.000 abstract 1
- 108010028554 LDL Cholesterol Proteins 0.000 description 28
- 150000003626 triacylglycerols Chemical class 0.000 description 14
- 235000019419 proteases Nutrition 0.000 description 13
- 108010023302 HDL Cholesterol Proteins 0.000 description 11
- 241000209094 Oryza Species 0.000 description 8
- 230000000694 effects Effects 0.000 description 8
- 238000005516 engineering process Methods 0.000 description 7
- 210000002381 plasma Anatomy 0.000 description 6
- 108010004032 Bromelains Proteins 0.000 description 5
- 108090000270 Ficain Proteins 0.000 description 5
- 108090000526 Papain Proteins 0.000 description 5
- 235000019835 bromelain Nutrition 0.000 description 5
- 235000019836 ficin Nutrition 0.000 description 5
- POTUGHMKJGOKRI-UHFFFAOYSA-N ficin Chemical compound FI=CI=N POTUGHMKJGOKRI-UHFFFAOYSA-N 0.000 description 5
- 235000019834 papain Nutrition 0.000 description 5
- 229940055729 papain Drugs 0.000 description 5
- 150000008105 phosphatidylcholines Chemical class 0.000 description 5
- 229940068065 phytosterols Drugs 0.000 description 5
- 239000003814 drug Substances 0.000 description 4
- 210000004204 blood vessel Anatomy 0.000 description 3
- GVJHHUAWPYXKBD-UHFFFAOYSA-N (±)-α-Tocopherol Chemical compound OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-UHFFFAOYSA-N 0.000 description 2
- 208000024172 Cardiovascular disease Diseases 0.000 description 2
- 230000002159 abnormal effect Effects 0.000 description 2
- 230000003143 atherosclerotic effect Effects 0.000 description 2
- 230000009286 beneficial effect Effects 0.000 description 2
- 235000005911 diet Nutrition 0.000 description 2
- 230000003203 everyday effect Effects 0.000 description 2
- 201000005577 familial hyperlipidemia Diseases 0.000 description 2
- 235000013305 food Nutrition 0.000 description 2
- 230000036039 immunity Effects 0.000 description 2
- 230000004060 metabolic process Effects 0.000 description 2
- 238000013546 non-drug therapy Methods 0.000 description 2
- 230000002265 prevention Effects 0.000 description 2
- 239000000126 substance Substances 0.000 description 2
- OYHQOLUKZRVURQ-NTGFUMLPSA-N (9Z,12Z)-9,10,12,13-tetratritiooctadeca-9,12-dienoic acid Chemical compound C(CCCCCCC\C(=C(/C\C(=C(/CCCCC)\[3H])\[3H])\[3H])\[3H])(=O)O OYHQOLUKZRVURQ-NTGFUMLPSA-N 0.000 description 1
- IIZPXYDJLKNOIY-JXPKJXOSSA-N 1-palmitoyl-2-arachidonoyl-sn-glycero-3-phosphocholine Chemical compound CCCCCCCCCCCCCCCC(=O)OC[C@H](COP([O-])(=O)OCC[N+](C)(C)C)OC(=O)CCC\C=C/C\C=C/C\C=C/C\C=C/CCCCC IIZPXYDJLKNOIY-JXPKJXOSSA-N 0.000 description 1
- 206010003210 Arteriosclerosis Diseases 0.000 description 1
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 1
- 208000001953 Hypotension Diseases 0.000 description 1
- 208000005016 Intestinal Neoplasms Diseases 0.000 description 1
- 108090001030 Lipoproteins Proteins 0.000 description 1
- 102000004895 Lipoproteins Human genes 0.000 description 1
- 102000018697 Membrane Proteins Human genes 0.000 description 1
- 108010052285 Membrane Proteins Proteins 0.000 description 1
- 229930003427 Vitamin E Natural products 0.000 description 1
- 238000009825 accumulation Methods 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- 125000001931 aliphatic group Chemical group 0.000 description 1
- 230000002929 anti-fatigue Effects 0.000 description 1
- 230000003110 anti-inflammatory effect Effects 0.000 description 1
- 208000011775 arteriosclerosis disease Diseases 0.000 description 1
- 238000013142 basic testing Methods 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 230000017531 blood circulation Effects 0.000 description 1
- 238000009835 boiling Methods 0.000 description 1
- 210000000170 cell membrane Anatomy 0.000 description 1
- 239000001913 cellulose Substances 0.000 description 1
- 229920002678 cellulose Polymers 0.000 description 1
- 235000010980 cellulose Nutrition 0.000 description 1
- 208000026106 cerebrovascular disease Diseases 0.000 description 1
- 230000001906 cholesterol absorption Effects 0.000 description 1
- 230000007812 deficiency Effects 0.000 description 1
- 230000037213 diet Effects 0.000 description 1
- 230000000378 dietary effect Effects 0.000 description 1
- 230000035622 drinking Effects 0.000 description 1
- 238000002651 drug therapy Methods 0.000 description 1
- 230000002526 effect on cardiovascular system Effects 0.000 description 1
- 235000019441 ethanol Nutrition 0.000 description 1
- 229960004756 ethanol Drugs 0.000 description 1
- WIGCFUFOHFEKBI-UHFFFAOYSA-N gamma-tocopherol Natural products CC(C)CCCC(C)CCCC(C)CCCC1CCC2C(C)C(O)C(C)C(C)C2O1 WIGCFUFOHFEKBI-UHFFFAOYSA-N 0.000 description 1
- 208000021822 hypotensive Diseases 0.000 description 1
- 230000001077 hypotensive effect Effects 0.000 description 1
- 239000008235 industrial water Substances 0.000 description 1
- 201000002313 intestinal cancer Diseases 0.000 description 1
- 235000010445 lecithin Nutrition 0.000 description 1
- 229940067606 lecithin Drugs 0.000 description 1
- 239000000787 lecithin Substances 0.000 description 1
- 108010022197 lipoprotein cholesterol Proteins 0.000 description 1
- 238000012423 maintenance Methods 0.000 description 1
- 238000005259 measurement Methods 0.000 description 1
- 230000007935 neutral effect Effects 0.000 description 1
- 235000021590 normal diet Nutrition 0.000 description 1
- 230000003647 oxidation Effects 0.000 description 1
- 238000007254 oxidation reaction Methods 0.000 description 1
- 150000002989 phenols Chemical class 0.000 description 1
- 235000020777 polyunsaturated fatty acids Nutrition 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 210000000813 small intestine Anatomy 0.000 description 1
- 230000000391 smoking effect Effects 0.000 description 1
- 150000003431 steroids Chemical class 0.000 description 1
- 238000003786 synthesis reaction Methods 0.000 description 1
- 238000012360 testing method Methods 0.000 description 1
- 238000002560 therapeutic procedure Methods 0.000 description 1
- 230000002792 vascular Effects 0.000 description 1
- 235000019165 vitamin E Nutrition 0.000 description 1
- 229940046009 vitamin E Drugs 0.000 description 1
- 239000011709 vitamin E Substances 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/105—Plant extracts, their artificial duplicates or their derivatives
- A23L33/11—Plant sterols or derivatives thereof, e.g. phytosterols
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/115—Fatty acids or derivatives thereof; Fats or oils
- A23L33/12—Fatty acids or derivatives thereof
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/17—Amino acids, peptides or proteins
- A23L33/18—Peptides; Protein hydrolysates
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/17—Amino acids, peptides or proteins
- A23L33/185—Vegetable proteins
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/20—Reducing nutritive value; Dietetic products with reduced nutritive value
- A23L33/21—Addition of substantially indigestible substances, e.g. dietary fibres
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Polymers & Plastics (AREA)
- Nutrition Science (AREA)
- Mycology (AREA)
- Engineering & Computer Science (AREA)
- Food Science & Technology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Botany (AREA)
- Molecular Biology (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Coloring Foods And Improving Nutritive Qualities (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Medicines Containing Plant Substances (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
The invention relates to a nutritive composition with a function of reducing blood fat. The nutritive composition comprises the following components in parts by weight: 10-30 parts of hydrolysis small-molecule protein powder, 5-20 parts of high Fischer ratio polypeptide, 30-50 parts of dietary fiber, 8-15 parts of germ flour, 5-15 parts of corn flour, 3-10 parts of phosphatidylcholine, 3-10 parts of phytosterol, 1-2 parts of omega-3 fatty acid, 0.01-0.05 part of lutein and 0.02-0.05 part of anthocyanin, wherein the germ flour is at least one in wheat germ flour and rice germ flour, and the mass percent concentration of total sterol in the phytosterol is not less than 90%. The nutritive composition can be used for inhibiting the absorption of the human body for cholesterol and fat, reducing the content of fat and low density lipoprotein cholesterin in plasma, preventing low density lipoprotein from being oxidized and preventing the hardening of the arteries.
Description
Technical field
The present invention relates to a kind of alimentation composition and application thereof of reducing blood lipid, particularly relate to a kind of not only can reducing blood lipid but also alimentation composition and the application thereof of concentration of low density lipoprotein cholesterol can be reduced.
Background technology
The absorption of lipid is extremely important for the maintenance of life, and it not only provides life metabolism institute energy requirement, also as one of cell membrane and lipoprotein lipid composition, and for the synthesis of steroid substance in body.But, if lipid picked-up too much, fat metabolism in blood can be made abnormal thus cause hyperlipemia, and lipid is also easy causes accumulation on vascular wall, hinder blood flow, and then cause atherosclerotic (AS), the cardiovascular and cerebrovascular disease serious harm human health caused thus.
Blood fat is the general name of T-CHOL, triglycerides and lipoid (as phosphatide) etc. in blood plasma, is generally T-CHOL (TC), triglycerides (TG), HDL-C (HDL-C) and LDL-C (LDL-C) to its basic test item.Show as TC, TG, LDL-C of high fat of blood raise, and HDL-C reduces.LDL-C is confirmed by many foreign studies as the Major Risk Factors of cardiovascular disease, and u.s. national cholesterol education program (NCEP) is using LDL-C as the deterministic standard reducing cholesterol.
In recent years, the scholar of a lot of country is studied the treatment of hyperlipemia, its treatment is roughly divided into medicine and the large class of non-drug therapy two, non-drug therapy being by motion of keeping on a diet, increase, removing other associated risk factor as discontinued the habit of smoking and drinking, and also still needs dietary therapy while drug therapy.
According to domestic and international achievement in research, found much have the food that LDL-C function particularly falls in reducing blood lipid, the main component wherein with effect for reducing blood fat has dietary fiber, polypeptide, aliphatic acid, phytosterol, phenolic compound and polysaccharose substance etc.; There is the main component of falling LDL-C effect and have phytosterol, ω-3 type polyunsaturated fatty acid, Soybean Peptide etc., often the edible effect that can reach reducing blood lipid.
The method of most reducing blood lipid needs Tighter control and depends on medicine clinically, and the side effect of blood lipid-lowering medicine makes it apply receives restriction to a certain degree.In prior art, temporarily can not reducing blood lipid and fall the relevant report of the alimentation composition of LDL-C concentration.
Summary of the invention
The object of the invention is to overcome above-mentioned the deficiencies in the prior art part and provide a kind of and both reducing blood lipid can reduce alimentation composition and the application thereof of concentration of low density lipoprotein cholesterol.
For achieving the above object, the technical scheme that the present invention takes is: a kind of alimentation composition of reducing blood lipid, the component containing following weight portion: 10 ~ 30 parts, hydrolysis small molecular protein powder, high F value oligopeptide 5 ~ 20 parts, dietary fiber 30 ~ 50 parts, germ flour 8 ~ 15 parts, corn flour 5 ~ 15 parts, phosphatid ylcholine 3 ~ 10 parts, phytosterol 3 ~ 10 parts, omega-fatty acid 1 ~ 2 part, 0.01 ~ 0.05 part, lutein, anthocyanidin 0.02 ~ 0.05 part; Wherein, described germ flour is at least one in wheat germ powder and rice germ powder, and in described phytosterol, the mass percent concentration of total sterol is not less than 90%.
As the preferred embodiment of the alimentation composition of reducing blood lipid of the present invention, described alimentation composition contains the component of following weight portion: 10 ~ 25 parts, hydrolysis small molecular protein powder, high F value oligopeptide 5 ~ 15 parts, dietary fiber 33 ~ 45 parts.
As the preferred embodiment of the alimentation composition of reducing blood lipid of the present invention, described hydrolysis small molecular protein powder with at least one material in rich selenium soybean and selenium-rich corn for gained prepared by raw material.More preferably, the preparation method of described hydrolysis small molecular protein powder is: take at least one material in rich selenium soybean and selenium-rich corn as raw material, adding water, is size mixing under the condition of 7.5 ~ 8.0 in pH value; Protease is added, in 50 ~ 55 DEG C of enzymolysis 4 hours in the slurries of gained after sizing mixing; Being heated to temperature is again 115 ~ 120 DEG C, makes enzyme-deactivating; After Vacuum Concentration enzyme-deactivating process products therefrom, in 130 ~ 135 DEG C of instantaneous sterilizings; Finally, inlet temperature be 170 DEG C, outlet temperature carries out spraying dry under being the condition of 80 DEG C, obtains hydrolysis small molecular protein powder.In preparation hydrolysis small molecular protein powder process, the protease added is the mixture of papain, bromelain and the ficin that GB2760 allows to use.
As the preferred embodiment of the alimentation composition of reducing blood lipid of the present invention, described high F value oligopeptide is that gained prepared by raw material with animal/vegetable protein.More preferably, the preparation method of described high F value oligopeptide is: in animal/vegetable protein, add water, is to size mixing under the condition of 7.0 ~ 7.5 in pH value; Protease is added, in 53 ~ 56 DEG C of enzymolysis 4 hours in gained slurries after sizing mixing; After enzymolysis 2 times, heat 15 minutes at 95 ~ 115 DEG C of temperature, make enzyme-deactivating; Centrifugal, filtration enzymolysis product, the filtrate obtained removes aromatic amino acid through ultrafiltration; Vacuum Concentration ultrafiltration gained filtrate, then in 130 ~ 135 DEG C of instantaneous sterilizings; Finally, inlet temperature be 170 DEG C, outlet temperature carries out spraying dry under being the condition of 80 DEG C, obtains high F value oligopeptide.Prepare in high F value oligopeptide process, the protease added is the mixture of papain, bromelain and the ficin that GB2760 allows to use.
As the preferred embodiment of the alimentation composition of reducing blood lipid of the present invention, described dietary fiber with at least one material in soybean, wheat, oat, oranges and tangerines, mung bean for gained prepared by raw material.More preferably, the preparation method of described dietary fiber was: take at least one material in soybean, wheat, oat, oranges and tangerines, mung bean as raw material, adding water, is after sizing mixing under the condition of 2.5 ~ 4.0 in pH value, heating, in 65 ~ 85 DEG C of hydrolysis 4 hours; Temperature be 35 DEG C, pressure adopts Ultra filtration membrane hydrolysate under being the condition of 0.08Mpa; After the material of Vacuum Concentration Ultra filtration membrane gained, inlet temperature be 180 DEG C, outlet temperature carries out spraying dry under being the condition of 90 DEG C, obtained dietary fiber.
Hydrolysis small molecular protein powder, high F value oligopeptide, dietary fiber, germ flour, corn flour, phosphatid ylcholine, phytosterol, omega-fatty acid, lutein, anthocyanidin mix obtained by above-mentioned weight portion by alimentation composition of the present invention.Wherein, described germ flour is at least one in wheat germ powder and rice germ powder, and in described phytosterol, the mass percent concentration of total sterol is not less than 90%; Hydrolysis small molecular protein powder, high F value oligopeptide, dietary fiber can preferably adopt said method to prepare.
In the alimentation composition of reducing blood lipid of the present invention, effect of each component is:
Hydrolysis small molecular protein powder: hydrolysis small molecular protein powder can improve body immunity, and can reduce the content of T-CHOL in human plasma (TC).
High F value oligopeptide: the content of T-CHOL (TC), triglycerides (TG), LDL-C (LDL-C) in high F value oligopeptide energy develop immunitypty, antifatigue, reduction blood plasma, can make the content of blood plasma middle-high density lipoprotein cholesterol (HDL-C) increase.
Dietary fiber: dietary fiber can shorten the time of food by small intestine, thus reduce cholesterol absorption.
Germ flour: germ flour can improve immunity, reduces the content of T-CHOL (TC) in blood.
Corn flour: containing a large amount of lecithin, linoleic acid, grain alcohol, vitamin E and cellulose etc. in corn flour, corn flour has the various health care functions such as hypotensive, reducing blood lipid, anti arteriosclerosis, prevention intestinal cancer.
Phosphatid ylcholine: phosphatid ylcholine can reduce the content of Blood Cholesterol and neutral fat, reduces the holdup time of fat at blood vessel.
Phytosterol: phytosterol has anti-inflammatory, promotes the katabolism of cholesterol, reduces LDL-C (LDL-C) effect that absorbs.
Omega-fatty acid: omega-fatty acid can reduce the content of T-CHOL in blood (TC), triglycerides (TG), LDL-C (LDL-C), makes the content of blood high-density lipoprotein cholesterol (HDL-C) raise.
Lutein, anthocyanidin: lutein, anthocyanidin can prevent LDL-C to be oxidized.
In addition, present invention also offers the application of described alimentation composition in reducing blood lipid.
Beneficial effect of the present invention is: alimentation composition of the present invention can suppress human body to the absorption of cholesterol, fat, reduces the content of fat and LDL-C in blood plasma, prevents LDL oxidation, prevention blood vessel scleratheroma.Further, the raw material that the present invention adopts is convenient to be bought, and security is high, side effect is little, solves the difficult problem that current LDL-C (LDL-C) difficulty reduces.
Accompanying drawing explanation
Fig. 1 is preparation technology's flow chart of hydrolysis small molecular protein powder of the present invention;
Fig. 2 is preparation technology's flow chart of high F value oligopeptide of the present invention;
Fig. 3 is preparation technology's flow chart of dietary fiber of the present invention.
Detailed description of the invention
In order to object of the present invention, technical scheme and beneficial effect are described better, below in conjunction with specific embodiment, the invention will be further described.
In embodiment, in preparation hydrolysis small molecular protein powder, high F value oligopeptide, dietary fiber process, water used is industrial water; Preparation is hydrolyzed in small molecular protein powder and high F value oligopeptide process, the protease added is the mixture of papain, bromelain and the ficin that GB2760 allows to use, and in mixture, the mass ratio of papain, bromelain and ficin is 1:1:1.Certainly, the mass ratio of papain, bromelain and ficin is not limited to 1:1:1, can select according to actual needs.
In embodiment, preparation technology's flow process of hydrolysis small molecular protein powder as shown in Figure 1; Preparation technology's flow process of high F value oligopeptide as shown in Figure 2; Preparation technology's flow process of dietary fiber as shown in Figure 3.
Embodiment 1
A kind of embodiment of the alimentation composition of reducing blood lipid of the present invention, described in the present embodiment, the alimentation composition of reducing blood lipid contains the component of following weight portion: 10 parts, hydrolysis small molecular protein powder, high F value oligopeptide 20 parts, dietary fiber 50 parts, wheat germ powder 8 parts, corn flour 5 parts, phosphatid ylcholine 3 parts, phytosterol 3 parts, omega-fatty acid 1 part, 0.01 part, lutein, anthocyanidin 0.05 part; Wherein, in described phytosterol, the mass percent concentration of total sterol is not less than 90%.
In the alimentation composition of above-mentioned reducing blood lipid, the preparation method of hydrolysis small molecular protein powder is: taking rich selenium soybean as raw material, add water, is size mixing under the condition of 7.5 in pH value; Protease is added, in 55 DEG C of enzymolysis 4 hours in the slurries of gained after sizing mixing; Being heated to temperature is again 118 DEG C, makes enzyme-deactivating; After Vacuum Concentration enzyme-deactivating process products therefrom, in 130 DEG C of instantaneous sterilizings; Finally, inlet temperature be 170 DEG C, outlet temperature carries out spraying dry under being the condition of 80 DEG C, obtains hydrolysis small molecular protein powder.
In the alimentation composition of above-mentioned reducing blood lipid, the preparation method of high F value oligopeptide is: in animal/vegetable protein, add water, is to size mixing under the condition of 7.5 in pH value; Protease is added, in 56 DEG C of enzymolysis 4 hours in gained slurries after sizing mixing; After enzymolysis 2 times, heat 15 minutes at 95 DEG C of temperature, make enzyme-deactivating; Centrifugal, filtration enzymolysis product, the filtrate obtained removes aromatic amino acid through ultrafiltration; Vacuum Concentration ultrafiltration gained filtrate, then in 135 DEG C of instantaneous sterilizings; Finally, inlet temperature be 170 DEG C, outlet temperature carries out spraying dry under being the condition of 80 DEG C, obtains high F value oligopeptide.
In the alimentation composition of above-mentioned reducing blood lipid, the preparation method of dietary fiber is: take soybean as raw material, add water, and after sizing mixing under pH value is 2.5 conditions, heating, in 65 DEG C of hydrolysis 4 hours; Temperature be 35 DEG C, pressure adopts Ultra filtration membrane hydrolysate under being the condition of 0.08Mpa; After the material of Vacuum Concentration Ultra filtration membrane gained, inlet temperature be 180 DEG C, outlet temperature carries out spraying dry under being the condition of 90 DEG C, obtained dietary fiber.
The preparation method of the alimentation composition of the reducing blood lipid of the present embodiment is: as stated above after obtained hydrolysis small molecular protein powder, high F value oligopeptide, dietary fiber, 10 parts of hydrolysis small molecular protein powder, 20 parts of high F value oligopeptides, 50 parts of dietary fibers, 8 parts of wheat germ powders, 5 parts of corn flour, 3 parts of phosphatid ylcholines, 3 parts of phytosterols (in phytosterol, the mass percent concentration of total sterol is not less than 90%), 1 part of omega-fatty acid, 0.01 part of lutein, 0.05 part of anthocyanidin are mixed, the alimentation composition of described reducing blood lipid can be obtained; Wherein, described part represents weight portion.
Embodiment 2
A kind of embodiment of the alimentation composition of reducing blood lipid of the present invention, described in the present embodiment, the alimentation composition of reducing blood lipid contains the component of following weight portion: 30 parts, hydrolysis small molecular protein powder, high F value oligopeptide 5 parts, dietary fiber 33 parts, wheat germ powder 10 parts, corn flour 15 parts, phosphatid ylcholine 3 parts, phytosterol 3 parts, omega-fatty acid 1 part, 0.05 part, lutein, anthocyanidin 0.02 part; Wherein, in described phytosterol, the mass percent concentration of total sterol is not less than 90%.
In the alimentation composition of above-mentioned reducing blood lipid, the preparation method of hydrolysis small molecular protein powder is: taking selenium-rich corn as raw material, add water, is size mixing under the condition of 8.0 in pH value; Protease is added, in 50 DEG C of enzymolysis 4 hours in the slurries of gained after sizing mixing; Being heated to temperature is again 115 DEG C, makes enzyme-deactivating; After Vacuum Concentration enzyme-deactivating process products therefrom, in 135 DEG C of instantaneous sterilizings; Finally, inlet temperature be 170 DEG C, outlet temperature carries out spraying dry under being the condition of 80 DEG C, obtains hydrolysis small molecular protein powder.
In the alimentation composition of above-mentioned reducing blood lipid, the preparation method of high F value oligopeptide is: in animal/vegetable protein, add water, is to size mixing under the condition of 7.0 in pH value; Protease is added, in 53 DEG C of enzymolysis 4 hours in gained slurries after sizing mixing; After enzymolysis 2 times, heat 15 minutes at 115 DEG C of temperature, make enzyme-deactivating; Centrifugal, filtration enzymolysis product, the filtrate obtained removes aromatic amino acid through ultrafiltration; Vacuum Concentration ultrafiltration gained filtrate, then in 130 DEG C of instantaneous sterilizings; Finally, inlet temperature be 170 DEG C, outlet temperature carries out spraying dry under being the condition of 80 DEG C, obtains high F value oligopeptide.
In the alimentation composition of above-mentioned reducing blood lipid, the preparation method of dietary fiber is: take wheat and oat as raw material by the mass ratio of 1:1, add water, and after sizing mixing under pH value is 4.0 conditions, heating, in 85 DEG C of hydrolysis 4 hours; Temperature be 35 DEG C, pressure adopts Ultra filtration membrane hydrolysate under being the condition of 0.08Mpa; After the material of Vacuum Concentration Ultra filtration membrane gained, inlet temperature be 180 DEG C, outlet temperature carries out spraying dry under being the condition of 90 DEG C, obtained dietary fiber.
The preparation method of the alimentation composition of the reducing blood lipid of the present embodiment is: as stated above after obtained hydrolysis small molecular protein powder, high F value oligopeptide, dietary fiber, 30 parts of hydrolysis small molecular protein powder, 5 parts of high F value oligopeptides, 33 parts of dietary fibers, 10 parts of wheat germ powders, 15 parts of corn flour, 3 parts of phosphatid ylcholines, 3 parts of phytosterols (in phytosterol, the mass percent concentration of total sterol is not less than 90%), 1 part of omega-fatty acid, 0.05 part of lutein, 0.02 part of anthocyanidin are mixed, the alimentation composition of described reducing blood lipid can be obtained; Wherein, described part represents weight portion.
Embodiment 3
A kind of embodiment of the alimentation composition of reducing blood lipid of the present invention, described in the present embodiment, the alimentation composition of reducing blood lipid contains the component of following weight portion: 25 parts, hydrolysis small molecular protein powder, high F value oligopeptide 15 parts, dietary fiber 30 parts, germ flour 15 parts, corn flour 7 parts, phosphatid ylcholine 3 parts, phytosterol 3 parts, omega-fatty acid 2 parts, 0.03 part, lutein, anthocyanidin 0.02 part; Wherein, described germ flour is mass ratio is the wheat germ powder of 1:1 and the mixture of rice germ powder, and in described phytosterol, the mass percent concentration of total sterol is not less than 90%.
In the alimentation composition of above-mentioned reducing blood lipid, the preparation method of hydrolysis small molecular protein powder is: taking selenium-rich corn as raw material, add water, is size mixing under the condition of 7.8 in pH value; Protease is added, in 53 DEG C of enzymolysis 4 hours in the slurries of gained after sizing mixing; Being heated to temperature is again 120 DEG C, makes enzyme-deactivating; After Vacuum Concentration enzyme-deactivating process products therefrom, in 132 DEG C of instantaneous sterilizings; Finally, inlet temperature be 170 DEG C, outlet temperature carries out spraying dry under being the condition of 80 DEG C, obtains hydrolysis small molecular protein powder.
In the alimentation composition of above-mentioned reducing blood lipid, the preparation method of high F value oligopeptide is: in animal/vegetable protein, add water, is to size mixing under the condition of 7.2 in pH value; Protease is added, in 55 DEG C of enzymolysis 4 hours in gained slurries after sizing mixing; After enzymolysis 2 times, heat 15 minutes at 105 DEG C of temperature, make enzyme-deactivating; Centrifugal, filtration enzymolysis product, the filtrate obtained removes aromatic amino acid through ultrafiltration; Vacuum Concentration ultrafiltration gained filtrate, then in 132 DEG C of instantaneous sterilizings; Finally, inlet temperature be 170 DEG C, outlet temperature carries out spraying dry under being the condition of 80 DEG C, obtains high F value oligopeptide.
In the alimentation composition of above-mentioned reducing blood lipid, the preparation method of dietary fiber was: take oranges and tangerines as raw material, add water, is after sizing mixing under the condition of 3.2 in pH value, heating, in 75 DEG C of hydrolysis 4 hours; Temperature be 35 DEG C, pressure adopts Ultra filtration membrane hydrolysate under being the condition of 0.08Mpa; After the material of Vacuum Concentration Ultra filtration membrane gained, inlet temperature be 180 DEG C, outlet temperature carries out spraying dry under being the condition of 90 DEG C, obtained dietary fiber.
The preparation method of the alimentation composition of the reducing blood lipid of the present embodiment is: as stated above after obtained hydrolysis small molecular protein powder, high F value oligopeptide, dietary fiber, 25 parts of hydrolysis small molecular protein powder, 15 parts of high F value oligopeptides, 30 parts of dietary fibers, 15 parts of germ flours, 7 parts of corn flour, 3 parts of phosphatid ylcholines, 3 parts of phytosterols (in phytosterol, the mass percent concentration of total sterol is not less than 90%), 2 parts of omega-fatty acids, 0.03 part of lutein, 0.02 part of anthocyanidin are mixed, the alimentation composition of described reducing blood lipid can be obtained; Wherein, described germ flour is mass ratio is the wheat germ powder of 1:1 and the mixture of rice germ powder, and described part represents weight portion.
Embodiment 4
A kind of embodiment of the alimentation composition of reducing blood lipid of the present invention, described in the present embodiment, the alimentation composition of reducing blood lipid contains the component of following weight portion: 18 parts, hydrolysis small molecular protein powder, high F value oligopeptide 12 parts, dietary fiber 45 parts, 8 parts, rice germ powder, corn flour 5 parts, phosphatid ylcholine 5 parts, phytosterol 5 parts, omega-fatty acid 2 parts, 0.03 part, lutein, anthocyanidin 0.03 part; Wherein, in described phytosterol, the mass percent concentration of total sterol is not less than 90%.
In the alimentation composition of above-mentioned reducing blood lipid, the preparation method of hydrolysis small molecular protein powder is: take rich selenium soybean and selenium-rich corn as raw material by the mass ratio of 1:1, adding water, is size mixing under the condition of 7.8 in pH value; Protease is added, in 53 DEG C of enzymolysis 4 hours in the slurries of gained after sizing mixing; Being heated to temperature is again 118 DEG C, makes enzyme-deactivating; After Vacuum Concentration enzyme-deactivating process products therefrom, in 132 DEG C of instantaneous sterilizings; Finally, inlet temperature be 170 DEG C, outlet temperature carries out spraying dry under being the condition of 80 DEG C, obtains hydrolysis small molecular protein powder.
In the alimentation composition of above-mentioned reducing blood lipid, the preparation method of high F value oligopeptide is: in animal/vegetable protein, add water, is to size mixing under the condition of 7.2 in pH value; Protease is added, in 53 DEG C of enzymolysis 4 hours in gained slurries after sizing mixing; After enzymolysis 2 times, heat 15 minutes at 105 DEG C of temperature, make enzyme-deactivating; Centrifugal, filtration enzymolysis product, the filtrate obtained removes aromatic amino acid through ultrafiltration; Vacuum Concentration ultrafiltration gained filtrate, then in 132 DEG C of instantaneous sterilizings; Finally, inlet temperature be 170 DEG C, outlet temperature carries out spraying dry under being the condition of 80 DEG C, obtains high F value oligopeptide.
In the alimentation composition of above-mentioned reducing blood lipid, the preparation method of dietary fiber was: take mung bean as raw material, add water, is after sizing mixing under the condition of 3.2 in pH value, heating, in 75 DEG C of hydrolysis 4 hours; Temperature be 35 DEG C, pressure adopts Ultra filtration membrane hydrolysate under being the condition of 0.08Mpa; After the material of Vacuum Concentration Ultra filtration membrane gained, inlet temperature be 180 DEG C, outlet temperature carries out spraying dry under being the condition of 90 DEG C, obtained dietary fiber.
The preparation method of the alimentation composition of the reducing blood lipid of the present embodiment is: as stated above after obtained hydrolysis small molecular protein powder, high F value oligopeptide, dietary fiber, 18 parts of hydrolysis small molecular protein powder, 12 parts of high F value oligopeptides, 45 parts of dietary fibers, 8 parts of rice part germ flours, 5 parts of corn flour, 5 parts of phosphatid ylcholines, 5 parts of phytosterols (in phytosterol, the mass percent concentration of total sterol is not less than 90%), 2 parts of omega-fatty acids, 0.03 part of lutein, 0.03 part of anthocyanidin are mixed, the alimentation composition of described reducing blood lipid can be obtained; Wherein, described part represents weight portion.
Embodiment 5
A kind of embodiment of the alimentation composition of reducing blood lipid of the present invention, described in the present embodiment, the alimentation composition of reducing blood lipid contains the component of following weight portion: 10 parts, hydrolysis small molecular protein powder, high F value oligopeptide 5 parts, dietary fiber 40 parts, 12 parts, rice germ powder, corn flour 11.5 parts, phosphatid ylcholine 10 parts, phytosterol 10 parts, omega-fatty acid 1.5 parts, 0.05 part, lutein, anthocyanidin 0.05 part; Wherein, in described phytosterol, the mass percent concentration of total sterol is not less than 90%.
In the present embodiment, the preparation method of hydrolysis small molecular protein powder, high F value oligopeptide, dietary fiber is all with embodiment 1.
The preparation method of the alimentation composition of the reducing blood lipid of the present embodiment is: after obtained hydrolysis small molecular protein powder, high F value oligopeptide, dietary fiber, 10 parts of hydrolysis small molecular protein powder, 5 parts of high F value oligopeptides, 40 parts of dietary fibers, 12 parts of rice part germ flours, 11.5 parts of corn flour, 10 parts of phosphatid ylcholines, 10 parts of phytosterols (in phytosterol, the mass percent concentration of total sterol is not less than 90%), 1.5 parts of omega-fatty acids, 0.05 part of lutein, 0.05 part of anthocyanidin are mixed, the alimentation composition of described reducing blood lipid can be obtained; Wherein, described part represents weight portion.
Embodiment 6
The usage and dosage of the alimentation composition of reducing blood lipid of the present invention is: every day takes 20 ~ 50g, and boiling water reconstitutes.Alimentation composition of the present invention not only can reducing blood lipid but also can reduce concentration of low density lipoprotein cholesterol.
In order to investigate the impact of alimentation composition of the present invention on T-CHOL in human plasma (TC), triglycerides (TG), HDL-C (HDL-C) and LDL-C (LDL-C), we have screened 30 abnormal people of health check-up four items of blood lipid tests (TC, TG, HDL-C, LDL-C), they are normal diet every day also edible alimentation composition 20g of the present invention, but do not take other blood lipid-lowering medicine; After eight weeks, measure TC, TG, HDL-C, LDL-C concentration in its blood, and with edible alimentation composition of the present invention before health check-up situation compare, measurement result is as shown in table 1 below:
Table 1
As known from Table 1, alimentation composition of the present invention has obvious effect in auxiliary reduction T-CHOL (TC), triglycerides (TG), LDL-C (LDL-C); Further, alimentation composition of the present invention can also assist the concentration raising HDL-C in blood of human body.As can be seen here, alimentation composition of the present invention can assist the content reducing Blood Cholesterol, and can reduce LDL-C LDL-C concentration, is conducive to preventing blood vessel scleratheroma and reducing the risk that angiocardiopathy occurs.
Finally to should be noted that; above embodiment is only in order to illustrate technical scheme of the present invention but not limiting the scope of the invention; although be explained in detail the present invention with reference to preferred embodiment; those of ordinary skill in the art is to be understood that; can modify to technical scheme of the present invention or equivalent replacement, and not depart from essence and the scope of technical solution of the present invention.
Claims (9)
1. an alimentation composition for reducing blood lipid, is characterized in that: described alimentation composition contains the component of following weight portion: 10 ~ 30 parts, hydrolysis small molecular protein powder, high F value oligopeptide 5 ~ 20 parts, dietary fiber 30 ~ 50 parts, germ flour 8 ~ 15 parts, corn flour 5 ~ 15 parts, phosphatid ylcholine 3 ~ 10 parts, phytosterol 3 ~ 10 parts, omega-fatty acid 1 ~ 2 part, 0.01 ~ 0.05 part, lutein, anthocyanidin 0.02 ~ 0.05 part; Wherein, described germ flour is at least one in wheat germ powder and rice germ powder, and in described phytosterol, the mass percent concentration of total sterol is not less than 90%.
2. the alimentation composition of reducing blood lipid as claimed in claim 1, is characterized in that: described alimentation composition contains the component of following weight portion: 10 ~ 25 parts, hydrolysis small molecular protein powder, high F value oligopeptide 5 ~ 15 parts, dietary fiber 33 ~ 45 parts.
3. the alimentation composition of reducing blood lipid as claimed in claim 1, is characterized in that: described hydrolysis small molecular protein powder with at least one material in rich selenium soybean and selenium-rich corn for gained prepared by raw material.
4. the alimentation composition of reducing blood lipid as claimed in claim 3, it is characterized in that: the preparation method of described hydrolysis small molecular protein powder is: take at least one material in rich selenium soybean and selenium-rich corn as raw material, adding water, is size mixing under the condition of 7.5 ~ 8.0 in pH value; Protease is added, in 50 ~ 55 DEG C of enzymolysis 4 hours in the slurries of gained after sizing mixing; Being heated to temperature is again 115 ~ 120 DEG C, makes enzyme-deactivating; After Vacuum Concentration enzyme-deactivating process products therefrom, in 130 ~ 135 DEG C of instantaneous sterilizings; Finally, inlet temperature be 170 DEG C, outlet temperature carries out spraying dry under being the condition of 80 DEG C, obtains hydrolysis small molecular protein powder.
5. the alimentation composition of reducing blood lipid as claimed in claim 1, is characterized in that: described high F value oligopeptide is that gained prepared by raw material with animal/vegetable protein.
6. the alimentation composition of reducing blood lipid as claimed in claim 5, it is characterized in that: the preparation method of described high F value oligopeptide is: in animal/vegetable protein, add water, is size mixing under the condition of 7.0 ~ 7.5 in pH value; Protease is added, in 53 ~ 56 DEG C of enzymolysis 4 hours in gained slurries after sizing mixing; After enzymolysis 2 times, heat 15 minutes at 95 ~ 115 DEG C of temperature, make enzyme-deactivating; Centrifugal, filtration enzymolysis product, the filtrate obtained removes aromatic amino acid through ultrafiltration; Vacuum Concentration ultrafiltration gained filtrate, then in 130 ~ 135 DEG C of instantaneous sterilizings; Finally, inlet temperature be 170 DEG C, outlet temperature carries out spraying dry under being the condition of 80 DEG C, obtains high F value oligopeptide.
7. the alimentation composition of reducing blood lipid as claimed in claim 1, is characterized in that: described dietary fiber with at least one material in soybean, wheat, oat, oranges and tangerines, mung bean for gained prepared by raw material.
8. the alimentation composition of reducing blood lipid as claimed in claim 7, it is characterized in that: the preparation method of described dietary fiber is: take at least one material in soybean, wheat, oat, oranges and tangerines, mung bean as raw material, add water, be after sizing mixing under the condition of 2.5 ~ 4.0 in pH value, heating, in 65 ~ 85 DEG C of hydrolysis 4 hours; Temperature be 35 DEG C, pressure adopts Ultra filtration membrane hydrolysate under being the condition of 0.08Mpa; After the material of Vacuum Concentration Ultra filtration membrane gained, inlet temperature be 180 DEG C, outlet temperature carries out spraying dry under being the condition of 90 DEG C, obtained dietary fiber.
9. the application of alimentation composition in reducing blood lipid described in any one of claim 1 ~ 8.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201410624532.2A CN104351778B (en) | 2014-11-07 | 2014-11-07 | The alimentation composition of a kind of blood fat reducing and application thereof |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201410624532.2A CN104351778B (en) | 2014-11-07 | 2014-11-07 | The alimentation composition of a kind of blood fat reducing and application thereof |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CN104351778A true CN104351778A (en) | 2015-02-18 |
| CN104351778B CN104351778B (en) | 2016-09-14 |
Family
ID=52519169
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN201410624532.2A Active CN104351778B (en) | 2014-11-07 | 2014-11-07 | The alimentation composition of a kind of blood fat reducing and application thereof |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN104351778B (en) |
Cited By (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN105475855A (en) * | 2015-11-28 | 2016-04-13 | 吉林农业大学 | High-fiber mung bean protein peptide composite nutrition food and green production method thereof |
| CN107048422A (en) * | 2017-04-17 | 2017-08-18 | 通泰心脑健康管理有限公司 | A kind of nutritional preparation of patients with cerebral apoplexy rehabilitation |
| CN109744532A (en) * | 2017-11-01 | 2019-05-14 | 北京神飞航天应用技术研究院 | A kind of suitable spacefarer adjusts the solid beverage and preparation method thereof of blood lipid and improvement memory |
Citations (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1650750A (en) * | 2004-04-30 | 2005-08-10 | 南阳市海达生物技术有限公司 | Food for reducing blood sugar and blood fat and its preparation method |
| CN101019914A (en) * | 2007-03-23 | 2007-08-22 | 童宥霖 | Soft capsule containing lutein and its prepn |
| CN103349051A (en) * | 2013-06-17 | 2013-10-16 | 南阳市新天地生物科技有限公司 | Biscuits suitable for hyperlipoidemia crowd |
| CN103719852A (en) * | 2013-12-25 | 2014-04-16 | 广州施健生物科技有限公司 | Dietetic food composition for losing weight |
-
2014
- 2014-11-07 CN CN201410624532.2A patent/CN104351778B/en active Active
Patent Citations (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1650750A (en) * | 2004-04-30 | 2005-08-10 | 南阳市海达生物技术有限公司 | Food for reducing blood sugar and blood fat and its preparation method |
| CN101019914A (en) * | 2007-03-23 | 2007-08-22 | 童宥霖 | Soft capsule containing lutein and its prepn |
| CN103349051A (en) * | 2013-06-17 | 2013-10-16 | 南阳市新天地生物科技有限公司 | Biscuits suitable for hyperlipoidemia crowd |
| CN103719852A (en) * | 2013-12-25 | 2014-04-16 | 广州施健生物科技有限公司 | Dietetic food composition for losing weight |
Non-Patent Citations (1)
| Title |
|---|
| 董青春等: "紫甘蓝提取物对Cu~(2+)介导的LDL氧化修饰的抑制作用", 《安徽农业科学》 * |
Cited By (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN105475855A (en) * | 2015-11-28 | 2016-04-13 | 吉林农业大学 | High-fiber mung bean protein peptide composite nutrition food and green production method thereof |
| CN105475855B (en) * | 2015-11-28 | 2019-01-22 | 吉林农业大学 | High microsteping mung bean protein peptide composite nutrient food and its Green production method |
| CN107048422A (en) * | 2017-04-17 | 2017-08-18 | 通泰心脑健康管理有限公司 | A kind of nutritional preparation of patients with cerebral apoplexy rehabilitation |
| CN109744532A (en) * | 2017-11-01 | 2019-05-14 | 北京神飞航天应用技术研究院 | A kind of suitable spacefarer adjusts the solid beverage and preparation method thereof of blood lipid and improvement memory |
Also Published As
| Publication number | Publication date |
|---|---|
| CN104351778B (en) | 2016-09-14 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Colletti et al. | Valorisation of by-products from soybean (Glycine max (L.) Merr.) processing | |
| CN106579393A (en) | Special clinical nutrient formula for diabetes and preparation method thereof | |
| JP5670750B2 (en) | Egg products with ingredients identified to lower cholesterol levels and / or improve health in humans | |
| Izadi et al. | Reducing blood cholesterol by a healthy diet. | |
| CN104783124A (en) | Probiotic table salt and preparing method thereof | |
| CN105613789A (en) | High-fat and high-dietary-fiber composite animal and plant powdered oil and preparation method and application thereof | |
| CN108606246A (en) | A kind of full cereal meal replacement powder of corn quinoa and preparation method thereof | |
| CN103445169A (en) | Instant germ mixing powder and preparation method thereof | |
| Soltanizadeh et al. | Strategies used in production of phenylalanine‐free foods for PKU management | |
| CN107440120A (en) | A kind of children's monophagia and anorexia tailored version clinical nutrition formula particular about food and preparation method thereof | |
| JP5830214B2 (en) | Orally administered composition | |
| CN107440121A (en) | A kind of Single Obesity tailored version clinical nutrition formula and preparation method thereof | |
| CN110074397A (en) | A kind of upgrowth and development of children tailored version clinical nutrition formula and preparation method thereof | |
| CN104855790A (en) | Oat electuary and manufacturing method therefor | |
| CN102389076A (en) | Composition for lowering cholesterol and preparation method thereof | |
| CN108703365A (en) | Protein allergy tailored version clinical nutrition formula and preparation method thereof | |
| WO2015124083A1 (en) | Beverage dissolved with phytosterol and production method therefor | |
| CN104351778A (en) | Nutritive composition with function of reducing blood fat, and application of nutritive composition | |
| Esmaeili et al. | Encapsulating, a feasible and promising approach to combat vitamin D deficiency | |
| CN102018070A (en) | Instant milk tea powder | |
| CN101991126A (en) | Xylitol black sesame paste green health-care food and preparation technology thereof | |
| CN105558260B (en) | Potato peptide nutrient food and preparation method thereof | |
| Boone-Villa et al. | Trends in functional food in non-communicable diseases | |
| CN108260802A (en) | A kind of gerontal patient's tailored version clinical nutrition formula and preparation method thereof | |
| Shanina et al. | Potato juice vs. traditional potato use—a new insight |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| ASS | Succession or assignment of patent right |
Owner name: TONGTAI MYOCARDIAL AND CEREBRAL HEALTH MANAGEMENT Free format text: FORMER OWNER: GUANGZHOU HONGTAI MEDICAL TECHNOLOGY CO., LTD. Effective date: 20150814 |
|
| C41 | Transfer of patent application or patent right or utility model | ||
| TA01 | Transfer of patent application right |
Effective date of registration: 20150814 Address after: 309, room 11, 510630 software Road, Guangdong, Guangzhou, Tianhe District Applicant after: TUNETAI SUMNO HEALTH MANAGEMENT CO., LTD. Address before: 3, 302, building 11, 510630 software Road, Tianhe Software Park, Guangdong, Guangzhou Applicant before: GUANGZHOU HTIDE MEDICAL TECHNOLOGY CO., LTD. |
|
| C14 | Grant of patent or utility model | ||
| GR01 | Patent grant | ||
| TR01 | Transfer of patent right | ||
| TR01 | Transfer of patent right |
Effective date of registration: 20190111 Address after: 510000 Room 303, 3/F, No. 11 Software Road, Tianhe Software Park, Tianhe District, Guangzhou City, Guangdong Province (This residence is for office use only) Patentee after: Guangzhou Ketogenic Medical Treatment Technology Co., Ltd. Address before: Room 309, No. 11 Software Road, Tianhe District, Guangzhou City, Guangdong Province Patentee before: TUNETAI SUMNO HEALTH MANAGEMENT CO., LTD. |
|
| TR01 | Transfer of patent right | ||
| TR01 | Transfer of patent right |
Effective date of registration: 20200623 Address after: 510000 room 311-a159, No.1, Mingzhu 1st Street, Hengli Town, Nansha District, Guangzhou City, Guangdong Province (office only) Patentee after: Guangzhou friendship Biological Technology Co.,Ltd. Address before: 510000 Room 303, 3/F, No. 11 Software Road, Tianhe Software Park, Tianhe District, Guangzhou City, Guangdong Province (This residence is for office use only) Patentee before: GUANGZHOU KETO MEDICAL TECHNOLOGY Co.,Ltd. |